32888-87-2Relevant academic research and scientific papers
Effect of the Metal within Regioisomeric Paddle-Wheel-Type Metal–Organic Frameworks
Ha, Hyeonbin,Kim, Youngik,Kim, Dopil,Lee, Jihyun,Song, Yoodae,Kim, Suyeon,Park, Myung Hwan,Kim, Youngjo,Kim, Hyungjun,Yoon, Minyoung,Kim, Min
supporting information, p. 14414 - 14420 (2019/11/03)
The effect of metal on the degree of flexibility upon evacuation of metal–organic frameworks (MOFs) has been revealed with positional control of the organic functionalities. Although Co-, Cu-, and Zn-based DMOFs (DMOF = DABCO MOF, DABCO = 1,4-diazabicyclo
Inhibitor for immune cell migration
-
Paragraph 0120-0122, (2019/05/16)
The invention discloses an inhibitor for immune cell migration. The inhibitor has the characteristic of a structure as shown in a following formula. The inhibitor has balanced hydrophilicity and lipotropy, can be developed into eyedrops easily and external applied plaster, has a high inhibitory effect on immune cell migration, and can alleviate most dry eye diseases and eczematous dermatitis and psoriasis.
Aromatic Substituent Effects on the Flexibility of Metal-Organic Frameworks
Hahm, Hyungwoo,Yoo, Kwangho,Ha, Hyeonbin,Kim, Min
, p. 7576 - 7581 (2016/08/06)
The flexibility (or breathing behavior) of zinc-based metal-organic frameworks (MOFs) has been manipulated by regioisomeric and positional control of organic functionalities. Ten new regioisomeric BDC (ortho- or para-disubstituted benzene-1,4-dicarboxylic
Metal-organic framework regioisomers based on bifunctional ligands
Kim, Min,Boissonnault, Jake A.,Dau, Phuong V.,Cohen, Seth M.
supporting information; experimental part, p. 12193 - 12196 (2012/01/30)
Regioisomeric MOFs: A series of bifunctional metal-organic framework (MOF) regioisomers has been produced from amino-halo benzene dicarboxylate (NH 2X-BDC) ligands. ZrIV- and ZnII-based MOFs were synthesized and for the fl
PROLYL HYDROXYLASE INHIBITORS
-
Page/Page column 25-26, (2010/07/10)
The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
NOVEL BICYCLIC AROMATIC COMPOUNDS, THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS
-
Page 63, (2010/02/08)
The invention relates to novel aromatic bicycle compounds of formula (I), wherein Ar, X, Y and R1-R3 are such as specified in a claim 1. Said invention also relates to the tautomers, enantiomers, diasteriomers, mixtures, pro-drugs an
